Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouChanging contract manufacturers is usually framed as a commercial decision. In practice, it is a data-transfer project — and the asset most often lost in the handover is the stability file. A new manufacturer…
Changing contract manufacturers is usually framed as a commercial decision. In practice, it is a data-transfer project — and the asset most often lost in the handover is the stability file. A new manufacturer can reproduce a formula and still fail a retailer audit, a customs query, or a marketplace takedown if the shelf-life claim on the artwork cannot be traced back to comparable data. This guide explains what to request, in what order, and which numbers you cannot accept at face value when hair care production moves from one site to another.
Stability is not a single report. When you change manufacturers, three distinct layers have to move — and most buyers only ask for the third one.
| Asset | What it is | Who typically holds it | Minimum acceptable format |
|---|---|---|---|
| Golden Stability Profile | Reference baseline: formula version, process version, T0 target, expected trend, acceptable range, red flag, archived raw data/images | Outgoing manufacturer | Signed PDF plus the underlying data tables |
| Stability raw dataset | Timepoint results by condition and orientation | Outgoing manufacturer / lab | Excel or LIMS export, not a summary slide |
| Micro & preservative efficacy | Total counts, specified organisms, PET results | Third-party lab | Report with method, limits, and pass/fail |
| Method definitions | pH, viscosity, foam, sensory and panel protocols | Outgoing manufacturer | Written SOP references, not just numbers |
| Retain sample records | Batch-linked retained units in controlled storage | Outgoing manufacturer | Storage location, conditions, review plan |
The scope of the stability work is decided by what actually changed — not by how similar the two formulas look on paper. Ask for a written change classification with your RFQ so both sides are working from the same premise.
The single most useful document in a manufacturer transfer is the reference baseline for the formula as originally validated. Without it, the new site’s data has nothing to be compared against, and “the results look fine” becomes the only available verdict.
A usable profile contains, at minimum: SKU name, formula version, process version, T0 target (for example the target pH), expected trend across shelf life (for a well-behaved system, minimal drift), acceptable range tied to the SKU specification, the red-flag condition (typically any OOS result), and archived raw data or reference images.
Request it as a signed document with the underlying data attached. If the outgoing manufacturer will only provide a summary, ask for the raw timepoint tables on the specific parameters most likely to drift — pH, viscosity, appearance, odour, and emulsion or serum homogeneity.
Two labs can both report “viscosity: 4,200 cP” and mean different things. Before accepting any transferred result as equivalent to the legacy data, confirm the method behind it.
Where the new site’s method differs, ask for a method bridge study on the same retained batch — old method and new method run side by side — rather than a straight substitution.
Full performance testing on every batch is not realistic, so a competent quality system controls batch-to-batch consistency through proxy metrics that are linked to validated performance. For a shampoo, that combination is typically pH, viscosity, foam, and sensory attributes, measured on every batch against approved methods, with periodic performance studies and revalidation triggered by any formula, process, or raw material change.
Ask the incoming manufacturer to describe their proxy set for your SKU in writing. A supplier who cannot name their per-batch proxies is telling you something useful.
Most transfer failures that reach the consumer are not chemistry failures — they are interface failures. Request a dedicated compatibility study covering:
Accelerated conditions (commonly 40 °C / 75% RH) plus real-time retain storage is the standard evidence pattern. Get the report, not a verbal assurance.
Stability transfer and claims transfer are connected. If the shelf-life evidence weakens, the wording on pack and page becomes harder to defend. For hair care, confirm which claim the stability and performance data is actually supporting.
Retain samples are what make a future complaint investigation possible. Require controlled-environment storage, a batch-level inventory with formula version reference, and a defined review plan. Without retained units from the transferred production, any later stability question becomes unanswerable.
| Phase | Compressed path | Standard path | Evidence produced |
|---|---|---|---|
| Change classification & document handover | 2–3 weeks | 3–4 weeks | Signed change assessment, Golden Stability Profile, raw datasets |
| Method bridging | 1–2 weeks (on retained batch) | 3–4 weeks | Side-by-side bridge report |
| Pilot / first batch | 2–3 weeks | 4–6 weeks | Batch record, COA, per-batch proxy results |
| Accelerated stability & micro | 8–12 weeks (accelerated only, real-time continues) | 12–16 weeks plus ongoing real-time | Stability report, micro report, PET assessment |
| Packaging compatibility | 4–6 weeks (parallel) | 8–12 weeks (parallel) | Compatibility report, leak/dispensing results |
| Label & claims review | 1–2 weeks (parallel) | 2–3 weeks | Approved artwork, claim substantiation file |
The compressed path is only safe when the formula and raw material sources are genuinely unchanged, the packaging is unchanged, and the retained legacy batch is still available for bridging. It is not safe when a botanical extract, fragrance, or preservative system has changed.
Only as the reference baseline. It supports comparability; it does not substitute for data generated on product made at the new site. Retailers and regulators expect evidence tied to the batch you are actually selling.
Usually yes, at least an accelerated confirmation plus method bridging. Equipment, scale, mixing energy, and fill lines change the physical state of a formulation even when the formula card is unchanged.
It depends on what changed. A fragrance or botanical extract supplier change should at minimum trigger a documented PET re-assessment and a micro specification review, with the outcome signed off rather than assumed.
Any out-of-specification result should trigger a formal investigation before commercial release, benchmarked against the accepted range and expected trend in the reference profile. Do not average it away or extend the shelf life to compensate.
Real-time stability cannot be accelerated by will. What you can compress is decision speed: lock the change classification, request the reference profile and raw data in week one, run packaging compatibility in parallel, and start the pilot batch while method bridging is still in progress.
If you are moving a shampoo, conditioner, scalp serum, or treatment to a new manufacturing site, the fastest way to get an accurate scope and timeline is to send your SKU list, target market, current formula status, packaging direction, and shelf-life target in one brief. Request a Quote and we will map the stability and documentation transfer against your launch date.